Ebola virus disease

ST Jacob, I Crozier, WA Fischer, A Hewlett… - Nature reviews Disease …, 2020 - nature.com
Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus
(EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission …

Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission report

FM Knaul, PE Farmer, EL Krakauer, L De Lima… - The Lancet, 2018 - thelancet.com
In agonising, crippling pain from lung cancer, Mr S came to the palliative care service in
Calicut, Kerala, from an adjoining district a couple of hours away by bus. His body language …

[HTML][HTML] Nutrition support in the time of SARS-CoV-2 (COVID-19)

A Laviano, A Koverech, M Zanetti - Nutrition (Burbank, Los Angeles …, 2020 - ncbi.nlm.nih.gov
Nutrition is a key determinant of health [1]. More importantly, nutrition is part of the treatment
regimen for acute and chronic diseases and applies particularly to ailments for which an …

Evaluation of convalescent plasma for Ebola virus disease in Guinea

J Van Griensven, T Edwards… - … England Journal of …, 2016 - Mass Medical Soc
Background In the wake of the recent outbreak of Ebola virus disease (EVD) in several
African countries, the World Health Organization prioritized the evaluation of treatment with …

Clinical management of Ebola virus disease in the United States and Europe

TM Uyeki, AK Mehta, RT Davey Jr… - … England Journal of …, 2016 - Mass Medical Soc
Background Available data on the characteristics of patients with Ebola virus disease (EVD)
and clinical management of EVD in settings outside West Africa, as well as the …

Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea

D Sissoko, C Laouenan, E Folkesson… - PLoS …, 2016 - journals.plos.org
Background Ebola virus disease (EVD) is a highly lethal condition for which no specific
treatment has proven efficacy. In September 2014, while the Ebola outbreak was at its peak …

Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort …

L Hunt, A Gupta-Wright, V Simms, F Tamba… - The Lancet infectious …, 2015 - thelancet.com
Summary Background Clinical management of Ebola virus disease remains challenging.
Routine laboratory analytics are often unavailable in the outbreak setting, and few data exist …

Ebola virus disease

NJ Beeching, M Fenech, CF Houlihan - Bmj, 2014 - bmj.com
This clinical review has been developed for The BMJ in collaboration with BMJ Best
Practice, based on a regularly updated web/mobile topic that supports evidence-based …

The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States

CS Kraft, AL Hewlett, S Koepsell… - Clinical Infectious …, 2015 - academic.oup.com
Abstract Background. The current West Africa Ebola virus disease (EVD) outbreak has
resulted in multiple individuals being medically evacuated to other countries for clinical …

[HTML][HTML] Ebola virus disease: An emerging and re-emerging viral threat

M Rojas, DM Monsalve, Y Pacheco… - Journal of …, 2020 - Elsevier
The genus Ebolavirus from the family Filoviridae is composed of five species including
Sudan ebolavirus, Reston ebolavirus, Bundibugyo ebolavirus, Taï Forest ebolavirus, and …